These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6407502)
41. Affective disorders in general practice. Treatment of 6000 patients with fluvoxamine. Martin AJ; Tebbs VM; Ashford JJ Pharmatherapeutica; 1987; 5(1):40-9. PubMed ID: 3110794 [TBL] [Abstract][Full Text] [Related]
42. The tolerance and antidepressive activity of fluvoxamine as a single dose compared to a twice daily dose. Siddiqui UA; Chakravarti SK; Jesinger DK Curr Med Res Opin; 1985; 9(10):681-90. PubMed ID: 3935377 [TBL] [Abstract][Full Text] [Related]
43. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637 [TBL] [Abstract][Full Text] [Related]
44. A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice. Laws D; Ashford JJ; Anstee JA Acta Psychiatr Scand; 1990 Feb; 81(2):185-9. PubMed ID: 2109498 [TBL] [Abstract][Full Text] [Related]
45. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients. Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439 [TBL] [Abstract][Full Text] [Related]
46. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression. Samuelian JC; Hackett D J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254 [TBL] [Abstract][Full Text] [Related]
47. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives. Emrich HM; Berger M; Riemann D; von Zerssen D Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909 [TBL] [Abstract][Full Text] [Related]
48. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291 [TBL] [Abstract][Full Text] [Related]
49. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Mullin JM; Pandita-Gunawardena VR; Whitehead AM Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864 [No Abstract] [Full Text] [Related]
50. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Pöldinger W; Calanchini B; Schwarz W Psychopathology; 1991; 24(2):53-81. PubMed ID: 1909444 [TBL] [Abstract][Full Text] [Related]
51. Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine. Ansseau M; von Frenckell R; Gérard MA; Mertens C; De Wilde J; Botte L; Devoitille JM; Evrard JL; De Nayer A; Darimont P Eur Neuropsychopharmacol; 1991 May; 1(2):113-21. PubMed ID: 1821700 [TBL] [Abstract][Full Text] [Related]
52. Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine. Nielsen NP; Cesana B; Zizolfi S; Ascalone V; Priore P; Morselli PL Acta Psychiatr Scand; 1990 Nov; 82(5):366-71. PubMed ID: 2281807 [TBL] [Abstract][Full Text] [Related]
53. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression. Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983 [TBL] [Abstract][Full Text] [Related]
54. Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action. Price LH; Charney DS; Delgado PL; Anderson GM; Heninger GR Arch Gen Psychiatry; 1989 Jul; 46(7):625-31. PubMed ID: 2500111 [TBL] [Abstract][Full Text] [Related]
55. Fluvoxamine treatment of obsessive-compulsive disorder. Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604 [TBL] [Abstract][Full Text] [Related]
56. Double blind test with mianserin versus chlorimipramine. Rapisarda V; Bongiorno G Adv Biochem Psychopharmacol; 1982; 32():141-9. PubMed ID: 6283807 [TBL] [Abstract][Full Text] [Related]
57. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group. Psychopharmacology (Berl); 1986; 90(1):131-8. PubMed ID: 2876451 [TBL] [Abstract][Full Text] [Related]
58. Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression. Larsen JK; Gjerris A; Holm P; Anderson J; Bille A; Christensen EM; Høyer E; Jensen H; Mejlhede A; Langagergaard A Acta Psychiatr Scand; 1991 Dec; 84(6):564-70. PubMed ID: 1792931 [TBL] [Abstract][Full Text] [Related]
59. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382 [TBL] [Abstract][Full Text] [Related]